Vanta™ SCS Neurostimulator Non-rechargeable Spinal Cord Stimulation
Vanta™ SCS gives you an advantage over pain. This revolutionary non-rechargeable device offers optimized longevity, DTM™ SCS endurance programming, and unmatched MRI access.
Contact us
Overview
Your advantage
over pain
Learn about Vanta™ SCS.
Product details
High-performance recharge-free neurostimulator
Vanta™ SCS is a high-performance recharge-free device offering optimized longevity.
- Approximately 2x longer lasting than other devices at comparable settings*†
- 5½–7½ years of recharge-free longevity estimated using actual 12-month DTM™ SCS endurance therapy programming data1
Product specifications
Compatible with:
- MyStim™ PC smart patient therapy app model A72200
- Clinician programmer model CT900 with software app A71200 and trialing app A71300
- 16-electrode Specify™ SureScan™ MRI surgical leads
- Vectris™ SureScan™ MRI percutaneous leads
- INJEX™ anchoring system models 97791 and 97792
Model specifications
| Model | 977006 |
|---|---|
| Channels | 2 |
| Width | 1.1 cm (.44in) |
| Battery Type | Recharge-free |
Clinical evidence for DTM™ SCS endurance therapy2:
Meaningful pain reduction
↓4.6
cm reduction in VAS for overall
pain from baseline to 12-months
Quality of life improvements
76%
of patients improved in degree
of disability at 12-months
Therapy satisfaction
86%
of patients were
satisfied with therapy at 12-months
Unmatched full-body MRI access
- SureScan™ MRI technology allows MRI scans anywhere on the body‡ enabling diagnostic care.
- Provide patients the same access as non-implanted patients‡ — now and in the future.
- Shielded leads and proprietary device safeguards help patients safely get an MRI.‡
- Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.3
Read about DTM™ SCS
Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven.1
Learn more
Visit Medtronic Academy
and access detailed product information, including spec sheets, videos, and presentations.
Visit Medtronic Academy
*
Settings used from Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency. 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Energy modeling is the same for model 3660 and model 3670.
†
Settings from Boston Scientific's Alpha™ IFU. Programmed at 4.1mA, 280us. 40Hz. 1 area, 730 Ohms, 2 contacts.
‡
Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.
§
Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
1
Provenzano, Amirdelfan, Grewal, et al. Modeling energy demands of a reduced-energy derivative of DTM™ stimulation on rechargeable and recharge-free SCS systems. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.
2
Provenzano, Peacock, Fishman, et al. A prospective multi-center study of a reduced-energy DTM™ stimulation derivative: Long-term outcomes in therapy naïve patients. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.
3
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537